Doug Given, MD, PhD, MBA

Managing Partner, CEO & Director, Health 2047 Capital Partners
Chairman, CEO & President, Vivaldi Biosciences Inc.
Managing Partner, G5 Partners
Advisor, Bay City Capital
MBA, University of Pennsylvania Wharton
MD/PhD, University of Chicago Pritzker School of Medicine

image

Dr. Given has served as Chairman, Chief Executive Officer and President of Vivaldi Biosciences Inc. since its founding. He also is Chairman of the Supervisory Board of Vivaldi Biosciences AG. Dr. Given is a Managing Partner of G5 Partners and is an advisor to Bay City Capital, where he was an Investment Partner for ten years. Previously, he was Chief Executive Officer and a director of NeoRx, and Corporate Senior Vice President and Chief Technology Officer of Mallinckrodt. Prior to joining Mallinckrodt, Dr. Given served as Chief Executive Officer and a director of Progenitor and Mercator Genetics. Previously, he held positions as Vice President at Schering-Plough Research Institute, Vice President at Monsanto / GD Searle Research Laboratories, and Medical Advisor at Lilly Research Laboratories. Dr. Given is Chairman of Arrowhead Research Corp. and Chairman of Medical eXellence, Inc. He also has served on the boards of directors of eight private and eight public biomedical companies. Dr. Given is Chairman of the Visiting Committee to the Medical Center, Division of Biological Sciences and the Pritzker School of Medicine at the University of Chicago, a member of the Johns Hopkins Bloomberg School of Public Health Advisory Board, and a member of the International Advisory Committee, Harvard School of Public Health. Dr. Given received a BS degree in Physical Sciences from Colorado State University. He holds an MD with honors and a PhD from the University of Chicago, and an MBA from the Wharton School, University of Pennsylvania. He was a fellow in Internal Medicine and Infectious Diseases at Harvard Medical School and Massachusetts General Hospital.